Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
The Surgical Prostatectomy versus Interstitial Radiation Intervention Trial or SPIRIT was a Phase III, partially randomized clinical trial, conducted in the U.S.A. and Canada, and designed to compare radical prostatectomy (RP) and brachytherapy (BT) as first-line treatments for men with localized prostate cancer.
Filed under: Management, Treatment | Tagged: brachytherapy, HRQOL, localized, outcome, quality of life, radical prostatectomy, SPIRIT | Leave a Comment »
It has long been recognized that the combination of prostate cancer and diabetes tends to have a notable impact on the health-related quality of life (HRQoL) of male patients.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: diabetes, HRQOL, quality of life | Leave a Comment »
Data to be published in the May 2010 issue of the Journal of Urology are going to make a lot of urologists rather less than happy about the implications for the use of radical prostatectomy as first-line treatment for prostate cancer.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, comparison, cryotherapy, HRQOL, outcome, quality of life, radical prostatectomy, RALP, RP | Leave a Comment »
Today’s news reports summarize papers recently published on: Optimism, pessimism, and long-term health outcomes External beam radiation + hormone therapy for high-risk patients Quality of life and health utility after radical prostatectomy Paclitaxel + estradiol combination therapy in men progressing after docetaxel-based chemotherapy
Filed under: Management, Living with Prostate Cancer, Treatment, Drugs in development | Tagged: radical prostatectomy, quality of life, outcomes, radiation, "high risk", hormone therapy, HRQOL, paclitaxel, estradiol, optimism, pessimism | Leave a Comment »
Having high socioeconomic status AND being in a strong, positive, and supportive relationship may have improved the health-related quality of life (HRQOL) of men with localized prostate cancer, according to a recent study.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: HRQOL, partners, quality of life | 1 Comment »
The decisions patients and their doctors make about which treatment to select as first-line therapy for localized prostate cancer are commonly based on perceptions and expectations about the side effects of these treatments, as well as on the curative potential of the therapy.
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: comparison, first line, HRQOL, outcomes, quality of life, Treatment | Leave a Comment »
In today’s news reports we address: Prediction of freedom from biochemical failure after brachytherapy Prediction of probability of unilateral prostate cancer in men eligible for focal therapy Health-related quality of life 5 years after radiotherapy + androgen deprivation Androgen receptor activity “signatures” in men with CRPC
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: androgen receptor activity, brachytherapy, CRPC, dose, focal therapy, HRQOL, outcome, quality of life, signature, unilateral | Leave a Comment »
It is well known to readers of The “New” Prostate Cancer InfoLink that androgen deprivation therapy (ADT) is a commonly used form of treatment for patients who experience biochemical recurrence (BCR) after first- or second-line therapy. However, as is also well known, the optimal timing of ADT initiation is uncertain, and earlier initiation of ADT [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, anxiety, hormone therapy, HRQOL, quality of life | 3 Comments »
There are several news items again today. They deal with: Health-related quality of life of disadvantaged prostate cancer patients Post-surgical continence and preservation of the lateral fascia Relative health-related quality of life after radical prostatectomy and brachytherapy The activities of the protease-activated receptors PAR1 and PAR2 Lymph node assessment and lymphadenectomy in management of prostate [...]
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: brachytherapy, continence, HRQOL, lymph node assessment, lymphadenectomy, mortality, protease-activated receptors, quality of life, radical prostatecftomy, serum calcium | Leave a Comment »
Today’s news report contains items on: The estimation of localized prostate cancer tumor size based on PSA data alone Mitochondrial genes and prostate cancer risk Results of a Phase II trial of strontium-89 with chemohormonal therapy in men with metastatic bone disease The association between spirituality and quality of life in low-income patients with metastatic disease [...]
Filed under: Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: chemohormonal therapy, HRQOL, mitochondrial genes, quality of life, spirituality, strontium-89, tumor size | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site